Request that the FDA determine whether Dilaudid-HP (hydromorphone hydrochloride) 10 mg/mL, (NDA 019034) held by Fresenius Kabi USA LLC has been voluntarily withdrawn or withheld from sale for reasons of safety or efficacy
🏛 Food and Drug Administration (FDA)FDA-2026-P-2718
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.